Prophylactic cranial irradiation for limited non‐small cell lung cancer

Brian R. Griffin, Robert B. Livingston, Glenn R. Stewart, Celestia Higano, Kenneth J. Russell, Thomas W. Griffin, George E. Laramore

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


Seventy‐three patients with biopsy‐proven limited non‐small cell lung cancer (NSCLC) were entered on a combined modality study at the University of Washington. Seventy‐five percent (55 of 73) of the patients had a histologic diagnosis of adenocarcinoma or large cell carcinoma, whereas 25% (18 of 73) had squamous cell carcinoma. After two cycles of chemotherapy, patients without evidence of progressive disease received prophylactic cranial irradiation (PCI) and chest radiotherapy, followed by two additional cycles of chemotherapy. Brain computed tomography (CT) scans were performed at 3‐month intervals after completion of therapy in all patients, and were additionally performed whenever signs or symptoms developed suggesting neurologic dysfunction or recurrent brain disease. Sixty‐five patients were treated with PCI. No clinical or CT evidence of recurrence in the brain has developed in patients who completed PCI. PCI appears to be effective in greatly reducing the incidence of brain relapse in patients with limited NSCLC.

Original languageEnglish (US)
Pages (from-to)36-39
Number of pages4
Issue number1
StatePublished - Jul 1 1988
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Prophylactic cranial irradiation for limited non‐small cell lung cancer'. Together they form a unique fingerprint.

Cite this